CEO: Jacqualyn A. Fouse

Sector: Health Technology

Exchange: NASDAQ

Country: US

Description: Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Key numbers

Market Capitalization:2802414555
Shares Outstanding: 69110100
Float: 61274328
Next Earning Date:2020-10-29
TTm EPS: -5.3048
TTm Dividend Rate:
200 days moving average:45.44
50 days moving average: 49.72
One day percent Change: 3.34

2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,